Table 2 Drugs or biologics investigated in clinical trials related to hip fractures
From: Characteristics of clinical trials related to hip fractures and factors associated with completion
Drugs | Classifications | Number of clinical trialsa |
|---|---|---|
Bupivacaine | Local anesthetic | 25 |
Ropivacaine | Local anesthetic | 23 |
Tranexamic acid | Hemostatic | 21 |
Fentanyl | Pain killer | 9 |
Vitamin D | Anti-osteoporotic | 8 |
Morphine | Pain killer | 7 |
Teriparatide | Anti-osteoporotic | 6 |
Dexmedetomidine | α2-adrenergic receptor agonist | 4 |
Risedronate | Anti-osteoporotic | 4 |
Lidocaine | Local anesthetic | 4 |
enoxaparin | Antithrombotic agent | 4 |
Sevoflurane | Inhalation anesthetic | 4 |
Propofol | General anesthetic | 4 |
Testosterone | Anti-osteoporotic | 3 |